1-15 of 926
Cardiometabolic Considerations in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeCardiometabolic Considerations in Familial Chylomicronemia Syndrome
Steve Jackson, PharmD
Robert H. Eckel, MD, FAHA, FACC, FNLA
Rethinking Risk in Heart Failure with Preserved Ejection Fraction
Heart MattersRethinking Risk in Heart Failure with Preserved Ejection Fraction
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Heart MattersConnecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
The Cardiovascular Dimension of Psoriatic Arthritis
Living RheumThe Cardiovascular Dimension of Psoriatic Arthritis
Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Heart MattersSteroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
Steve Jackson, PharmD
Robert J. Mentz, MD, FHFSA, FACC
- advertisement
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
Primary Care Takeaways From VESALIUS-CV: Evolocumab Efficacy in Patients Without Significant Atherosclerosis
CardiologyPrimary Care Takeaways From VESALIUS-CV: Evolocumab Efficacy in Patients Without Significant Atherosclerosis
Javier Morales, MD, FACP, FACE
Value of Earlier Lipid-Lowering Therapy Intensification With Evolocumab in High-Risk Populations Without Known Significant ASCVD and With Diabetes: VESALIUS-CV Insights
CardiologyValue of Earlier Lipid-Lowering Therapy Intensification With Evolocumab in High-Risk Populations Without Known Significant ASCVD and With Diabetes: VESALIUS-CV Insights
Dr. Robert Giugliano
Rethinking Cardiovascular Risk: Uncovering the Blind Spots
Conversations in CV Risk AssessmentRethinking Cardiovascular Risk: Uncovering the Blind Spots
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Elevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Conversations in CV Risk AssessmentElevating CV Risk Assessment: Why uACR Deserves a Seat at the Table
Brian P. McDonough, MD, FAAFP
Javier Morales, MD, FACP, FACE
Primary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Conversations in CV Risk AssessmentPrimary Care and Cardiology: Shared Responsibility in Albuminuria Detection
Jennifer Caudle, DO, FACOFP
Javed Butler, MD, MPH, MBA
Martha Gulati, MD, MS, FACC
- advertisement
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Heart MattersAthlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Benjamin Levine, MD, FACC
Understanding CPET for Athletes: Protocols and Pitfalls
Heart MattersUnderstanding CPET for Athletes: Protocols and Pitfalls
Benjamin Levine, MD, FACC
Leveraging Wearables for Pulmonary Arterial Hypertension Care
Clinician's RoundtableLeveraging Wearables for Pulmonary Arterial Hypertension Care
Daniel Lachant, D.O.
